Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-assisted Immunoinflammatory Subtyping-Directed Precision Treatment in Acute Aortic Dissection: A Multicenter RCT-based Exploration

NCT07382375 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT07382375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07382375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI-assisted Immunoinflammatory Subtyping-Directed Precision Treatment in Acute Aortic Dissection: A Multicenter RCT-based Exploration
Lead sponsor
Nanjing Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2027
Completion date
December 31, 2027
Enrollment
300 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

aortic aneurysm and dissection